254 related articles for article (PubMed ID: 37242454)
1. The STAT3-Regulated Autophagy Pathway in Glioblastoma.
Laribee RN; Boucher AB; Madireddy S; Pfeffer LM
Pharmaceuticals (Basel); 2023 Apr; 16(5):. PubMed ID: 37242454
[TBL] [Abstract][Full Text] [Related]
2. The Role of Hypoxia and Cancer Stem Cells in Development of Glioblastoma.
Shi T; Zhu J; Zhang X; Mao X
Cancers (Basel); 2023 May; 15(9):. PubMed ID: 37174078
[TBL] [Abstract][Full Text] [Related]
3. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
[TBL] [Abstract][Full Text] [Related]
4. Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance.
Shi Y; Guryanova OA; Zhou W; Liu C; Huang Z; Fang X; Wang X; Chen C; Wu Q; He Z; Wang W; Zhang W; Jiang T; Liu Q; Chen Y; Wang W; Wu J; Kim L; Gimple RC; Feng H; Kung HF; Yu JS; Rich JN; Ping YF; Bian XW; Bao S
Sci Transl Med; 2018 May; 10(443):. PubMed ID: 29848664
[TBL] [Abstract][Full Text] [Related]
5. Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres.
Mukthavaram R; Ouyang X; Saklecha R; Jiang P; Nomura N; Pingle SC; Guo F; Makale M; Kesari S
J Transl Med; 2015 Aug; 13():269. PubMed ID: 26283544
[TBL] [Abstract][Full Text] [Related]
6. Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance.
Eckerdt F; Platanias LC
Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444568
[TBL] [Abstract][Full Text] [Related]
7. Autophagy Regulation on Cancer Stem Cell Maintenance, Metastasis, and Therapy Resistance.
Wang X; Lee J; Xie C
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053542
[TBL] [Abstract][Full Text] [Related]
8. STAT3 Enhances Sensitivity of Glioblastoma to Drug-Induced Autophagy-Dependent Cell Death.
Remy J; Linder B; Weirauch U; Day BW; Stringer BW; Herold-Mende C; Aigner A; Krohn K; Kögel D
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053502
[TBL] [Abstract][Full Text] [Related]
9. Nanomedicines Targeting Glioma Stem Cells.
Sabu A; Liu TI; Ng SS; Doong RA; Huang YF; Chiu HC
ACS Appl Mater Interfaces; 2023 Jan; 15(1):158-181. PubMed ID: 35544684
[TBL] [Abstract][Full Text] [Related]
10. Targeting Glioblastoma Stem Cells: A Review on Biomarkers, Signal Pathways and Targeted Therapy.
Tang X; Zuo C; Fang P; Liu G; Qiu Y; Huang Y; Tang R
Front Oncol; 2021; 11():701291. PubMed ID: 34307170
[TBL] [Abstract][Full Text] [Related]
11. Novel function of MDA-9/Syntenin (SDCBP) as a regulator of survival and stemness in glioma stem cells.
Talukdar S; Das SK; Pradhan AK; Emdad L; Shen XN; Windle JJ; Sarkar D; Fisher PB
Oncotarget; 2016 Aug; 7(34):54102-54119. PubMed ID: 27472461
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting DNA-PK induces glioma stem cell differentiation and sensitizes glioblastoma to radiation in mice.
Fang X; Huang Z; Zhai K; Huang Q; Tao W; Kim L; Wu Q; Almasan A; Yu JS; Li X; Stark GR; Rich JN; Bao S
Sci Transl Med; 2021 Jun; 13(600):. PubMed ID: 34193614
[TBL] [Abstract][Full Text] [Related]
13. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.
Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM
Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970
[TBL] [Abstract][Full Text] [Related]
14. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT
J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis.
Buccarelli M; Marconi M; Pacioni S; De Pascalis I; D'Alessandris QG; Martini M; Ascione B; Malorni W; Larocca LM; Pallini R; Ricci-Vitiani L; Matarrese P
Cell Death Dis; 2018 Aug; 9(8):841. PubMed ID: 30082680
[TBL] [Abstract][Full Text] [Related]
16. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
[TBL] [Abstract][Full Text] [Related]
17. Glioblastoma stem cell (GSC)-derived PD-L1-containing exosomes activates AMPK/ULK1 pathway mediated autophagy to increase temozolomide-resistance in glioblastoma.
Zheng Y; Liu L; Wang Y; Xiao S; Mai R; Zhu Z; Cao Y
Cell Biosci; 2021 Mar; 11(1):63. PubMed ID: 33789726
[TBL] [Abstract][Full Text] [Related]
18. MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy.
Huang T; Wan X; Alvarez AA; James CD; Song X; Yang Y; Sastry N; Nakano I; Sulman EP; Hu B; Cheng SY
Autophagy; 2019 Jun; 15(6):1100-1111. PubMed ID: 30654687
[TBL] [Abstract][Full Text] [Related]
19. Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells.
Ozawa Y; Yamamuro S; Sano E; Tatsuoka J; Hanashima Y; Yoshimura S; Sumi K; Hara H; Nakayama T; Suzuki Y; Yoshino A
Biochem Biophys Res Commun; 2020 Apr; 524(3):723-729. PubMed ID: 32035622
[TBL] [Abstract][Full Text] [Related]
20. MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells.
Fukasawa K; Lyu J; Kubo T; Tanaka Y; Suzuki A; Horie T; Tomizawa A; Osumi R; Iwahashi S; Tokumura K; Murata M; Kobayashi M; Todo T; Hirao A; Hinoi E
Cancer Res Commun; 2023 Jan; 3(1):148-159. PubMed ID: 36968222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
